Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
Jane Robertson(Cancer Research UK), J.H. Scarffe(The Christie Hospital), Maria Zambon(Public Health England), M Dougal(The Christie Hospital), Ken Mutton(Withington Community Hospital), SimonN. Jowitt(The Christie Hospital), K.R. Nagesh(The Christie Hospital), Heather Anderson(The Christie Hospital)
Cited by 208
Related Papers
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
|Journal of Clinical Investigation|2008|349
Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors
|Journal of Clinical Oncology|2007|303